|1.||Burnstock, Geoffrey: 1 article (01/2014)|
|2.||Ralevic, Vera: 1 article (01/2014)|
|3.||Staruschenko, Alexander: 1 article (07/2013)|
|4.||Palygin, Oleg: 1 article (07/2013)|
|5.||Burnstock, G: 1 article (02/2012)|
|6.||Souza, Diogo O: 1 article (08/2008)|
|7.||Kapczinski, Flavio: 1 article (08/2008)|
|8.||Lara, Diogo R: 1 article (08/2008)|
|9.||Soares, Jair C: 1 article (08/2008)|
|10.||Zarate, Carlos A: 1 article (08/2008)|
|1.||Bipolar Disorder (Mania)
08/01/2008 - "This study aimed to evaluate the efficacy and tolerability of the purinergic agents allopurinol and dipyridamole combined with lithium in bipolar mania. "
08/01/2008 - "A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania."
|2.||Hypertension (High Blood Pressure)
07/15/2013 - "Direct real-time measurements of purinergic agents and reactive oxygen species concentrations have been of great value in understanding the functional roles of these substances in a number of diseases including chronic kidney disease and hypertension. "
01/01/2014 - "The pathophysiology of blood vessels and therapeutic potential of purinergic agents in diseases, including hypertension, atherosclerosis, ischemia, thrombosis and stroke, diabetes, and migraine, is discussed. "
02/01/2012 - "Potential therapeutic strategies are considered for the treatment of visceral pain in such conditions as renal colic, interstitial cystitis and inflammatory bowel disease by purinergic agents, including P2X3 and P2X2/3 receptor antagonists that are orally bioavailable and stable in vivo and agents that modulate ATP release and breakdown."
|4.||Reactive Oxygen Species (Oxygen Radicals)
|5.||Adenosine Triphosphate (ATP)